A survey by professional services group KPMG has found that nearly half of CEOs surveyed expect normality to resume in 2022 rather than 2021.
According to the 2021 CEO Outlook Pulse Survey conducted in February and March, CEOs have a clearer, near-to mid-term strategy. In particular, close to half (45 per cent) articulated that a return to ‘normal’ will not occur this year.
Based on a survey of 500 CEOs in 11 key markets, the 2021 Pulse Survey provides a snapshot of CEOs’ views on business growth resumption, their views on vaccine distribution, their top-of-mind organisational risks, and business transformation priorities going forward.
Of those surveyed, 24 per cent of leaders say that their business has changed forever. More than half (55 per cent) of business leaders state they are concerned that not all of their employees will have access to a Covid-19 vaccine, which could put their operations or certain markets at a competitive disadvantage.
As a result, nearly two-thirds (61 per cent) of companies will await a successful vaccine rollout in key markets before they ask staff to return to the office.
Prudently, three-quarters (76 per cent) of companies will wait for governments in key markets to encourage businesses to return to normal, whereas just 5 per cent will do so based on the actions by their competitors or similar businesses.
A significant majority (90 per cent) of CEOs intend to ask employees to report when they have been vaccinated, which will help organisations consider measures to protect their workforce. However, a third (34 per cent) of global executives are worried about misinformation on Covid-19 vaccine safety and the potential this may have on employees choosing not to have it administered.